{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "Diagnosis",
      "Disease management",
      "Lab-on-a-chip",
      "POC",
      "Point-of-care",
      "SARS-COV-2"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "37378785",
  "DateCompleted": {
    "Year": "2023",
    "Month": "06",
    "Day": "30"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "06",
    "Day": "30"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1007/978-3-031-28012-2_27"
    ],
    "Journal": {
      "ISSN": "0065-2598",
      "JournalIssue": {
        "Volume": "1412",
        "PubDate": {
          "Year": "2023"
        }
      },
      "Title": "Advances in experimental medicine and biology",
      "ISOAbbreviation": "Adv Exp Med Biol"
    },
    "ArticleTitle": "Rapid Detection of SARS-CoV-2 Variants of Concern by Genomic Surveillance Techniques.",
    "Pagination": {
      "StartPage": "491",
      "EndPage": "509",
      "MedlinePgn": "491-509"
    },
    "Abstract": {
      "AbstractText": [
        "This chapter describes the application of genomic, transcriptomic, proteomic, and metabolomic methods in the study of SARS-CoV-2 variants of concern. We also describe the important role of machine learning tools to identify the most significant biomarker signatures and discuss the latest point-of-care devices that can be used to translate these findings to the physician's office or to bedside care. The main emphasis is placed on increasing our diagnostic capacity and predictability of disease outcomes to guide the most appropriate treatment strategies."
      ],
      "CopyrightInformation": "\u00a9 2023. The Author(s), under exclusive license to Springer Nature Switzerland AG."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laboratory of Neuroproteomics, Department of Biochemistry and Tissue Biology, Institute of Biology, University of Campinas (UNICAMP), Campinas, Brazil."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Psychiatry, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany."
          },
          {
            "Identifier": [],
            "Affiliation": "Laboratory of Translational Psychiatry, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany."
          }
        ],
        "LastName": "Guest",
        "ForeName": "Paul C",
        "Initials": "PC"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Meridian Bioscience, Unit 16, The Edge Business Centre, London, UK."
          }
        ],
        "LastName": "Hawkins",
        "ForeName": "Steve F C",
        "Initials": "SFC"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK."
          }
        ],
        "LastName": "Rahmoune",
        "ForeName": "Hassan",
        "Initials": "H"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Adv Exp Med Biol",
    "NlmUniqueID": "0121103",
    "ISSNLinking": "0065-2598"
  },
  "SupplMeshList": [
    "SARS-CoV-2 variants"
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Proteomics"
    },
    {
      "QualifierName": [
        "diagnosis",
        "genetics"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Genomics"
    }
  ]
}